Endocrinology

insight - Endocrinology

Potential Overdiagnosis of Thyroid Cancer Due to Increased Screening Prompted by GLP-1 Drug Warnings

Clinicians should be cautious about excessive thyroid screening in patients taking GLP-1 drugs due to the risk of overdiagnosis of thyroid cancer.

Thyroid Warning on GLP-1s Could Raise Overdiagnosis Risk

Unexpectedly High Prevalence of Hypercortisolism in Patients with Poorly Controlled Type 2 Diabetes

A surprisingly high proportion of patients with poorly controlled type 2 diabetes have hypercortisolism, suggesting the need to rethink screening and management approaches for this patient population.

Hypercortisolism Prevalence High in Poorly Controlled T2D

Semaglutide, a GLP-1 Receptor Agonist, Enhances Taste Sensitivity and Alters Brain Responses to Sweet Tastes in Women with Obesity

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, improves taste sensitivity, changes brain responses to sweet tastes, and alters the expression of genes associated with taste bud development in women with obesity.

Semaglutide Improves Taste Sensitivity in Women With Obesity

Elevated Sex Hormone Ratios Associated with Increased Metabolic Syndrome and Inflammation Risk in Adults

Imbalances in sex hormone ratios, specifically elevated free estradiol index (FEI) and free androgen index (FAI), are linked to increased risk of metabolic syndrome and inflammation across different age groups and genders.

Sex Hormone Ratios Tied to Metabolic Syndrome Risk

Endocrine Responses to Triptorelin in Women: A Comparative Study in Different Conditions

Triptorelin induces varied gonadotropin responses in women with different conditions.

About

Products | Resources

Insights